Biohaven Ltd.
BHVN stock score: 43/100
$14.69 · +25.02% · Scored Oct 22, 2026
- Technical
- 57
- Fundamental
- 30
- News
- —
The reading
Biohaven (BHVN) scores 43 out of 100, which reads weak, higher than 45% of Healthcare stocks and 26% of the 4,161 US stocks we score.
The composite is technicals and fundamentals weighted equally: technicals read 57, fundamentals 30.
Among the fundamentals, Insider Transactions at 100 and Institutional Ownership at 100 score highest, while Earnings Growth (5-Year) at 0 weighs the most against it.
On the daily chart, trend-following indicators average 72 and contrarian oscillators 44 — a split worth reading before trusting the technical total.
Since Jul 25, 2026 the composite has ranged from 31 to 66, and it is down 23 points over the period.
What’s driving the score
The strongest and weakest of the scorers that count toward BHVN’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
30Pulling it up
- Insider Transactions100
Insider transactions track recent buying and selling by company insiders.
- Institutional Ownership100
Institutional ownership measures the percentage held by professional investors.
- Quick Ratio99
Quick ratio measures a company's ability to meet short-term obligations with liquid assets.
Holding it back
- Earnings Growth (5-Year)0
5-year earnings growth evaluates long-term profit trajectory and consistency.
- Free Cash Flow Yield0
Free cash flow yield is free cash flow divided by market value: the cash a business generates for each dollar of its price.
- Price to Book Ratio0
Price-to-Book ratio compares market value to book value.
27 weighted scorers; 14 had no data today and are left out rather than counted as zero.
Technical · daily
69Pulling it up
- EMA 5100
Exponential Moving Average (5-period) gives more weight to recent prices, making it more responsive to new information than simple moving averages.
- Parabolic SAR (PSAR)100
Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.
- SMA 5100
Simple Moving Average (5-period) tracks the average price over the last 5 periods.
Holding it back
- Bollinger Bands (20)0
Bollinger Bands (20-period) plot standard deviations above and below a moving average.
- Chaikin Money Flow (20)4
Chaikin Money Flow (20-period) measures buying and selling pressure over 20 periods.
- S&P 500 52W Comparison5
S&P 500 52-week comparison evaluates the stock's annual performance relative to the broader market.
61 weighted scorers; 4 had no data today and are left out rather than counted as zero.
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 61 | 1 |
| Daily | 69 | 3 |
| Weekly | 52 | 2 |
| Monthly | 49 | 2 |
| Quarterly | 50 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Oct 22, 2026 | 43 |
| Oct 21, 2026 | 34 |
| Oct 20, 2026 | 34 |
| Oct 19, 2026 | 32 |
| Oct 18, 2026 | 31 |
| Oct 17, 2026 | 31 |
| Oct 16, 2026 | 31 |
| Oct 15, 2026 | 32 |
| Oct 14, 2026 | 31 |
| Oct 13, 2026 | 32 |
| Oct 12, 2026 | 34 |
| Oct 11, 2026 | 34 |
| Oct 10, 2026 | 34 |
| Oct 9, 2026 | 34 |
| Oct 8, 2026 | 33 |
| Oct 7, 2026 | 33 |
| Oct 6, 2026 | 34 |
| Oct 5, 2026 | 36 |
| Oct 4, 2026 | 35 |
| Oct 3, 2026 | 35 |
| Oct 2, 2026 | 35 |
| Oct 1, 2026 | 36 |
| Sep 30, 2026 | 38 |
| Sep 29, 2026 | 37 |
| Sep 28, 2026 | 36 |
| Sep 27, 2026 | 35 |
| Sep 26, 2026 | 35 |
| Sep 25, 2026 | 35 |
| Sep 24, 2026 | 37 |
| Sep 23, 2026 | 41 |
| Sep 22, 2026 | 43 |
| Sep 21, 2026 | 40 |
| Sep 20, 2026 | 39 |
| Sep 19, 2026 | 39 |
| Sep 18, 2026 | 39 |
| Sep 17, 2026 | 38 |
| Sep 16, 2026 | 34 |
| Sep 15, 2026 | 35 |
| Sep 14, 2026 | 35 |
| Sep 13, 2026 | 36 |
| Sep 12, 2026 | 36 |
| Sep 11, 2026 | 36 |
| Sep 10, 2026 | 36 |
| Sep 9, 2026 | 42 |
| Sep 8, 2026 | 41 |
| Sep 7, 2026 | 43 |
| Sep 6, 2026 | 43 |
| Sep 5, 2026 | 43 |
| Sep 4, 2026 | 44 |
| Sep 3, 2026 | 43 |
| Sep 2, 2026 | 44 |
| Sep 1, 2026 | 45 |
| Aug 31, 2026 | 45 |
| Aug 30, 2026 | 44 |
| Aug 29, 2026 | 44 |
| Aug 28, 2026 | 45 |
| Aug 27, 2026 | 46 |
| Aug 26, 2026 | 46 |
| Aug 25, 2026 | 43 |
| Aug 24, 2026 | 40 |
| Aug 23, 2026 | 41 |
| Aug 22, 2026 | 41 |
| Aug 20, 2026 | 46 |
| Aug 19, 2026 | 49 |
| Aug 18, 2026 | 45 |
| Aug 17, 2026 | 48 |
| Aug 16, 2026 | 50 |
| Aug 15, 2026 | 50 |
| Aug 14, 2026 | 50 |
| Aug 13, 2026 | 50 |
| Aug 12, 2026 | 49 |
| Aug 11, 2026 | 49 |
| Aug 10, 2026 | 48 |
| Aug 9, 2026 | 50 |
| Aug 8, 2026 | 50 |
| Aug 7, 2026 | 50 |
| Aug 6, 2026 | 49 |
| Aug 5, 2026 | 48 |
| Aug 3, 2026 | 48 |
| Aug 2, 2026 | 47 |
| Jul 31, 2026 | 64 |
| Jul 30, 2026 | 65 |
| Jul 29, 2026 | 64 |
| Jul 28, 2026 | 65 |
| Jul 27, 2026 | 66 |
| Jul 26, 2026 | 66 |
| Jul 25, 2026 | 66 |
Key facts
- Market cap
- $2.2B
- Sector
- Healthcare
- Industry
- Biotechnology
- Beta
- 3.20
- Risk grade (1–10)
- 6
- Next earnings
- Nov 9, 2026
Biotechnology peers
| Company | Market cap | Score |
|---|---|---|
| CLDX Celldex Therapeutics | $2.3B | 30 |
| FTRE Fortrea | $2.3B | 52 |
| AGIO Agios Pharmaceuticals | $2.2B | 49 |
| VCEL Vericel | $2.2B | 58 |
| IMNM Immunome | $2.2B | 41 |
| PHVS Pharvaris | $2.2B | 42 |
Questions
What is BHVN's stock score today?
BHVN scores 43/100 (Weak) as of Oct 22, 2026: technical 57, fundamental 30. Scores are recomputed every night.
Is BHVN a buy?
The score is not a buy or sell recommendation. A 43 says the technical and fundamental signals we measure lean weak today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the BHVN score calculated?
88 weighted scorers feed it today: 27 fundamental, scored against Healthcare ranges, and 61 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.